Be part of the knowledge.™

Rare and Orphan Diseases

389

LikeLikedUnlike

181-195 of 261

IgAN Explained: Key Differences from Other Kidney Conditions
Clinician's Roundtable
IgAN Explained: Key Differences from Other Kidney Conditions
- Mohamed Ibrahim, MB, BCh
  Peer
Nutritional Strategies for Managing IgA Nephropathy
Clinician's Roundtable
Nutritional Strategies for Managing IgA Nephropathy
- Jennifer Moore, MS, RDN, CSR, LDN
  Peer
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
NeuroFrontiers
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
Rare Kidney Disease: A Parent and Caregiver’s Perspective
Clinician's Roundtable
Rare Kidney Disease: A Parent and Caregiver’s Perspective
- Gates B. Colbert, MD
  Peer
- Kelly Helm
  Peer
Decoding Proteinuria: A Window into Kidney Health in IgAN
Clinician's Roundtable
Decoding Proteinuria: A Window into Kidney Health in IgAN
Reducing the ALS Diagnostic Delay: The Impacts of a Rapid Access Clinic
NeuroFrontiers
Reducing the ALS Diagnostic Delay: The Impacts of a Rapid Access Clinic
- Kelly G. Gwathmey, MD
  Peer
advertisement
ATTR Peripheral Neuropathy: How to Avoid Misdiagnosis
NeuroFrontiers
ATTR Peripheral Neuropathy: How to Avoid Misdiagnosis
- Morie Gertz, MD, MACP
  Peer
Advances in IgAN: New Frontiers in Biomarkers and Treatment
On the Frontlines of IgA Nephropathy
Advances in IgAN: New Frontiers in Biomarkers and Treatment
- Gates B. Colbert, MD
  Peer
- Edward Filippone, MD
  Peer
Managing High-Risk Myeloma: From Cytogenetic Abnormalities to Therapeutic Approaches
Project Oncology®
Managing High-Risk Myeloma: From Cytogenetic Abnormalities to Therapeutic Approaches
- Gareth Morgan, MD
  Peer
Risk Stratification Models for Precursor Diseases in Multiple Myeloma
Project Oncology®
Risk Stratification Models for Precursor Diseases in Multiple Myeloma
- Betsy O'Donnell, MD
  Peer
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
Project Oncology®
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
- Betsy O'Donnell, MD
  Peer
Optimizing the Screening of Precursor Diseases in Multiple Myeloma
Project Oncology®
Optimizing the Screening of Precursor Diseases in Multiple Myeloma
- Betsy O'Donnell, MD
  Peer
advertisement
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
NeuroFrontiers
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
- John Brandsema, MD
  Peer
Continuum of Care: Managing DMD in Pediatric and Adult Patients
NeuroFrontiers
Continuum of Care: Managing DMD in Pediatric and Adult Patients
- John Brandsema, MD
  Peer
Optimizing Multiple Myeloma Care: Advances for Newly Diagnosed Patients
Project Oncology®
Optimizing Multiple Myeloma Care: Advances for Newly Diagnosed Patients
- Morie Gertz, MD, MACP
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended